GL1X · GenesisL1 explorer

MolNFT v1 · #63242 · protein

Kinase domain of csrc in complex with inhibitor RL37 (type III)

3F3U · Proto-oncogene tyrosine-protein kinase src: “Kinase domain of csrc in complex with inhibitor RL37 (type III)”. X-ray diffraction, 1 ligand (1AW), 5 pockets (best druggability 0.76). MolNFT v1 #63242 on GenesisL1: 3D structure…

PDB
3F3U
Type
protein
Length
520 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
1AW
Pockets
5 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26142% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25940% helix, 17% strandP00523

Ligands and binding sites

  • 1AW · 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea · ligand · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19780.760.78831AW
24110.720.83461AW
33820.590.7640empty
4640.420.8122empty
5870.320.7312empty

Interfaces

1 interface between chains.

  • A–B · 394 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3F3U · Kinase domain of cSrc in complex with inhibitor RL37 (Type III) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.